Results at 24 weeks revealed that 76% of individuals achieved a 75% or more improvement in overall disease severity (EASI-75), trial's primary endpoint. Among a study population of adults and ...

For most teenagers, a psychosocial history is at least as important as the physical exam. This essential psychosocial history can be obtained using the HEEADSSS method of interviewing adolescents. The ...

In 2021, the American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, and the Children’s Hospital Association jointly declared a national emergency in child and adolescent ...

Rebecca Baum, chief, section of Development, Behavior, and Learning at the University of North Carolina, Hillsborough, North Carolina; and Katherine Wu, MD, FAAP, Pediatric Health Care Associates in ...

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know. Ultimately, there is a paucity of safety data for several ...

Providers must ask themselves two questions: How much do I know about social media; and how can I positively influence teenagers to practice safe behaviors on the available social media platforms?

Despite the growing involvement of fathers in their children’s lives, there persists a lack of focus on fathers in pediatric care. Updated guidelines can help pediatricians to better engage fathers in ...

Caregivers and parents should feel empowered to protect their children with sun-safe practices that include sunscreen, sun-protective clothing, and sun-safe activities. According to the American ...

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule. "I couldn't be more ...

Hair loss is a condition that is often distressing and difficult to treat, particularly in adolescents. Here’s what you should know. Most cases of pediatric alopecia are acquired; the causes are ...

The approval makes dupilumab the first and only treatment specifically indicated for eosinophilic esophagitis (EoE) patients aged 1 to 11 years that weigh at least 33 lbs (15 kg). Dupilumab (Dupixent; ...

The AI-enabled, wearable device is the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up. The FDA has approved an expanded pediatric indication for ...